Objective: The objective of this study was to estimate the effect of intrinsic sphincter deficiency (ISD) on frequency and urge incontinence after midurethral sling (MUS) in women with mixed urinary incontinence (MUI).
M ixed urinary incontinence (MUI) is a common condition that can be challenging to treat. The International Continence Society defines MUI as the complaint of involuntary leakage associated with urgency and also with exertion, effort, sneezing, or coughing. 1 The incidence of MUI has been reported to be between 30% and 50% of all women with urinary incontinence. 2 The pathophysiology of MUI remains unclear. It has been suggested that patients with MUI have 2 independent defects: a primary detrusor dysfunction and a primary weak outlet. Other experts theorize that the etiologies of stress and urge incontinence are linked and that detrusor overactivity is a reflex response stimulated by urinary leakage into the proximal urethra during Valsalva (urethral event theory). 3, 4 Midurethral slings (MUSs) have become widely accepted as the criterion-standard surgical treatment for stress urinary incontinence (SUI). Some studies indicate that urge urinary incontinence (UUI), and overactive bladder symptoms can resolve after MUS in approximately 50% of patients with MUI. 4, 5 However, it is clear that not all patients with MUI respond equally well to MUS placement. In general, women with urge predominant MUI have poorer results than those with stress predominant MUI. 6 However, retrospective studies attempting to identify clinical or urodynamic predictors of persistent detrusor overactivity and/or UUI after MUS have had mixed results. 7, 8 The concept of intrinsic sphincter deficiency (ISD) and its clinical relevance remain debated. Patients with urodynamic evidence of poor urethral sphincter function, such as lower leak point pressures and low urethral closure pressures, are said to have ISD. Presumably, a poorly functioning urethral closure mechanism would allow for more leakage of urine into the proximal urethra during Valsalva. Specifically, in women with MUI, this may result in worsening detrusor overactivity based on the urethral event theory. Clinically, women with ISD have more severe incontinence, and ISD has been associated with treatment failure in women undergoing MUS placement for predominant stress incontinence. 9,10 However, the scientific evidence supporting the use of ISD as a parameter to provide prognostic information about the success of anti-incontinence surgery is unclear.
The primary objective of this study was to estimate the effect of ISD on resolution of frequency and urge incontinence at 6 to 12 months after MUS in women with MUI. The secondary objective was to estimate the effect of ISD on resolution of stress incontinence in this same cohort of women.
MATERIALS AND METHODS
This study was approved by the institutional review board at Women and Infants Hospital (Providence, RI). We conducted a secondary analysis of retrospectively collected data including women who underwent MUS placement through the Division of Urogynecology at Women and Infants Hospital between June 2008 and July 2010. All patients underwent preoperative multichannel urodynamic testing confirming SUI. Demographic and clinical information was collected preoperatively and at 6 to 12 months after surgery. Data from the 12-month postoperative visit was used if it was available and questionnaires were complete. Otherwise, data from the 6 month postoperative visit were applied. Data on intraoperative surgical details and perioperative complications were also collected. Midurethral sling procedures included both retropubic and transobturator approaches at the discretion of the individual surgeon. All surgeries were performed by 1 of 6 fellowship-trained urogynecologists within the Division of Urogynecology. Incontinence severity was assessed using the Incontinence Severity Index (ISI). 11 All women completed the Pelvic Floor Distress Inventory 20 (PFDI) to measure symptom severity and the Pelvic Floor Impact Questionnaire 7 (PFIQ) to measure life impact preoperatively and postoperatively. 12 For this analysis, we included only the subset of women with preoperative MUI, defined as an affirmative response to the urge incontinence item (no. 16) on the PFDI. This is consistent with the International Continence Society/International Urogynecological Association Joint Report, which defines MUI as ''involuntary loss of urine associated with urgency and also with effort or physical exertion or on coughing or sneezing.'' 1 Women who did not complete the PFDI preoperatively or at 6 to 12 months after surgery were excluded. Women were categorized into 2 groups, those with ISD and MUI (ISD-MUI) and those without ISD (nonYISD-MUI) at baseline. Intrinsic sphincter deficiency was defined as a positive abdominal leak point pressure of less than 60 cm H 2 O and/or maximum urethral closure pressure less than 20 cm H 2 O on preoperative urodynamic testing. 13 Leak point pressures were measured during filling cystometry, with the patient sitting upright. Valsalva and cough were both used to provoke leakage at a bladder volume of 200 mL. Both leak point pressure and maximum urethral closure pressure were used to define ISD to capture as many women as possible with urethral dysfunction. Presence or absence of urethral hypermobility was not used to define ISD in our cohort.
Our primary outcome was postoperative resolution of urinary frequency and urge incontinence as assessed by responses to PFDI items 15 and 16, in composite at 6 to 12 months after surgery. Item 15 asks ''Do you usually experience frequent urination?'' Item 16 asks ''Do you usually experience urine leakage associated with a feeling of urgency, that is, a strong sensation of needing to go to the bathroom?'' We also assessed for resolution of each of these symptoms separately. Our secondary outcome was resolution of stress incontinence as assessed by PFDI item 17 at 6 to 12 months after surgery. This item reads ''Do you usually experience urine leakage related to coughing, sneezing, or laughing?'' We defined resolution of these symptoms as a negative response to the corresponding items. We also assessed for postoperative improvements in frequency and urge incontinence. We defined improvement as improvement in bother (postoperative score lower than baseline score) to PFDI items 15 and 16. Within-group and betweengroup improvements in symptom severity and life impact were compared using the urinary subscales of the PFDI and PFIQ, the Urinary Distress Inventory (UDI), and the Urinary Impact Questionnaire (UIQ), utilizing paired and independent t tests, respectively. Categorical variables were compared by Fisher exact test; continuous variables were compared using analysis of variance or nonparametric Wilcoxon sum rank test. A multivariable logistic regression model was constructed to estimate 
RESULTS
During the study period, 423 women underwent MUS placement, and 137 women met our study inclusion criteria. Two hundred nineteen women who underwent MUS procedure in our study period were excluded for incomplete questionnaires. Seventy-four percent of the women who were excluded for incomplete questionnaires at follow-up did meet criteria for MUI at baseline. Of the eligible women with MUI, 15 (11%) had ISD, and 122 (89%) did not have ISD. Patient demographic, clinical, and urodynamic characteristics are presented in Table 1 . Women with ISD were older than women without ISD at baseline (63 vs 54 years, P = 0.01). Other demographic and clinical data (parity, race, body mass index, comorbidities, baseline ISI, UDI and IIQ scores, duration of incontinence, and concomitant procedures) did not differ between groups. The majority of women had retropubic slings, and the proportion of retropubic versus transobturator slings did not differ between the 2 groups.
Consistent with our predetermined criteria for defining ISD, women with ISD-MUI had lower baseline leak point pressures compared with women with nonYISD-MUI (50 vs 109 cm H 2 O; P G 0.0001). There was no difference in baseline maximum urethral closure pressure between groups (49 vs 59 cm H 2 O; P = 0.19). A higher proportion of women with ISD-MUI did have detrusor overactivity on preoperative urodynamic testing compared with those with nonYISD-MUI (60% vs 30%, P = 0.02).
Postoperatively, 42% of all women, with and without ISD, had complete resolution of both urinary frequency and UUI. Overall, 61% of women had complete resolution of urinary frequency, and 67% of all women had complete resolution of UUI. Comparing outcomes between groups, 67% of women with ISD-MUI versus 39% of women with nonYISD-MUI had complete resolution of both urinary frequency and urge incontinence (P = 0.04). Eighty-six percent of women with ISD-MUI versus 58% with nonYISD-MUI had complete resolution of urinary frequency (P = 0.04). Eighty percent of women with ISD-MUI versus 66% with nonYISD-MUI reported complete resolution of urge incontinence (P = 0.38). There was no difference between groups in postoperative resolution of stress incontinence symptoms (85% vs 90%, P = 0.63) or negative postoperative cough stress test between groups (90% vs 99%, P = 0.19). There was no difference in postoperative anticholinergic use between ISD-MUI and nonYISD-MUI groups (13% vs 11%; P = 0.87). In 67 women with complaints of SUI only at baseline (negative responses to the PFDI items for urge incontinence and frequency), the rate of de novo urge incontinence and/or frequency at 6 to 12 months after surgery was 19%. Postoperatively, women in both groups had significant improvements in UDI-6 and UIQ-7 scores (P G 0.001 for both). Between groups, there was no difference in mean improvements in scores of either subscale (UDI$ = 54 vs 46 and UIQ$ = 33 vs 33 for ISD-MUI vs nonYISD-MUI, respectively, P 9 0.05 for both). Postoperative outcomes are presented in Table 2 .
We performed a multivariable logistic regression controlling for age and presence of preoperative detrusor overactivity. On multiple logistic regression, women with ISD-MUI had an increased odds of experiencing complete resolution of urge incontinence and urinary frequency compared with women without ISD (adjusted odds ratio [AOR], 5.38; 95% confidence interval [CI], 1.50Y19.3) after adjusting for age and preoperative anticholinergic use. Because of the small number of women in the ISD group, we also chose to perform logistic regression controlling for each of these variables separately. After adjusting for age alone, women with ISD-MUI had an increased odds of experiencing complete resolution of urge incontinence and urinary frequency compared with women without ISD (AOR, 3.76; 95% CI, 1.15Y12.3). Adjusting for the presence of preoperative detrusor overactivity alone yielded similar results (AOR, 4.68; 95% CI, 1.37Y16.0).
DISCUSSION
There continue to be conflicting data regarding outcomes after MUS surgery in women with MUI. In our study, we found that a significant proportion of women with MUI experienced improvement in urinary frequency and urge incontinence symptoms after MUS placement. In addition, women with preoperative ISD had increased odds of experiencing complete resolution of urinary frequency and urge incontinence. However, there was no difference between groups in associated improvements in quality of life postoperatively. In addition, the proportion of women on postoperative anticholinergics did not differ between groups.
It is possible that there are various etiologies for MUI symptoms, and clinically meaningful definitions remain elusive. A recently published study by Brubaker et al 14 explored operational definitions of MUI in women with urge predominant MUI enrolled in the Urinary Incontinence Treatment Network BE-DRI clinical trial. In this nonsurgical patient population, definitions of MUI were created based on use of various baseline incontinence measures. The proportion of women with MUI varied significantly by definition used ranging from 63.5% to 96.4%. This inherent complexity often makes treatment of MUI difficult because, for patients, a ''successful'' outcome requires improvements of both stress and urge symptoms. If the etiologies of stress and urge incontinence are linked, and leakage of urine into the proximal urethra during Valsalva stimulates a reflex detrusor contraction, one would expect that patients with significant urethral dysfunction would have worse urge. 3 Alternatively, if there are 2 independent defects, a primary detrusor dysfunction and a primary weak outlet, significant urethral dysfunction could still lead to worse urge-associated leakage. Surgical outlet correction should lead to improvement of urge symptoms in either case.
Segal et al 15 retrospectively evaluated 98 women with urinary incontinence, 65 with mixed incontinence and 33 with stress incontinence, who underwent MUS surgery. Urinary symptoms, including stress incontinence, urge incontinence, and overactive bladder symptoms (urgency, frequency, and nocturia) were defined based on patients' perception of their symptoms on a standardized history. In the study of Segal et al, the urge component resolved in 63% of those with preoperative symptoms of mixed incontinence, and overactive bladder symptoms resolved in 57% of those with preoperative overactive bladder symptoms. These findings are very comparable to the findings our study, in which 67% of women had complete resolution of UUI, and 61% had complete resolution of urinary frequency. Assessed as separate outcomes, Segal et al also assessed the incidence of de novo irritative symptoms in this population and found the overall rate to be 13%, with de novo urge incontinence symptoms in 9% of women and de novo overactive bladder symptoms in 4% of women. Our overall rate of de novo urge incontinence and/or frequency symptoms was slightly higher at 19%. This may in part be reflective of the higher rate of baseline detrusor overactivity (31%) in our cohort in comparison to the cohort of Segal et al (6%). Although there were 17 patients who had evidence of ISD (by LPP G60 cm H 2 O or MUCP G20 cm H 2 O) at baseline in the study of Segal et al, urinary outcomes were not assessed separately in this group.
Barber et al 16 conducted a randomized controlled trial comparing tension-free vaginal tape to transobturator tape in patients with urodynamic stress incontinence, 73% of whom had self-reported MUI. In this study, there was no association between leak point pressures and development of any recurrent incontinence. Urge incontinence and frequency outcomes were not assessed separately in this study. In addition, this study excluded patients with preoperative detrusor overactivity on urodynamic testing, whereas 31% of our patient population had preoperative detrusor overactivity. If detrusor overactivity is indeed related to urethral sphincter dysfunction, surgically addressing this dysfunction with MUS may indeed lead to decreased postoperative detrusor overactivity and thus improved urge outcomes.
Conversely, in a planned secondary analysis of data from the Trial of Midurethral Slings, Nager et al 10 reported that a leak point pressure or urethral closure pressure in the lowest quartile conferred an almost 2-fold increase in the odds of objective failure after sling in patients with predominant SUI. Receiver operating characteristic analyses did not reveal any obvious thresholds for leak point pressure or urethral closure pressure that predicted failure. Although this trial did identify ISD as a risk factor for objective treatment failure, objective treatment failure was defined as positive stress test, positive pad test, or retreatment for SUI. Symptoms of urge incontinence and frequency were not assessed separately. Also, Paick et al 17 have previously published a prospective trial of 73 women with MUI in which preoperative maximal urethral closure pressure was the only independent risk factor associated with persistent urge incontinence after tension-free vaginal tape procedure on multivariate analysis. In our patient population, despite defining ISD as a positive abdominal leak point pressure of less than 60 cm H 2 O and/or maximum urethral closure pressure less than 20 cm H 2 O on preoperative urodynamics, there was no difference in maximum urethral closure pressure between our groups at baseline. Thus, we cannot comment on the association between urethral closure pressures and the resolution of urge incontinence symptoms in our study. Also, our patient population included only women with MUI, whereas the previous studies included pure SUI or stress-predominant MUI patient populations. Few other studies have attempted to identify predictors of persistent detrusor overactivity or urge incontinence after sling surgery in patients with MUI. 7, 8, 18 There are also conflicting data regarding stress incontinence outcomes after MUS in MUI. A recently published systematic review and meta-analysis of 13 trials assessing the efficacy of MUSs in women with MUI found that, although there is evidence of persistent and good cure of the stress component (85%Y97%), cure of the urge component is variable (30%Y85%) and often transient. 19 In addition, some authors have reported lower stress incontinence cure rates after MUS in women with mixed incontinence compared with those with pure stress incontinence. 20 We found that equal proportions of women with ISD-MUI and nonYISD-MUI experienced resolution of their stress incontinence symptoms. Our rates of both objective (90% and 99%) and subjective (80% and 85%) cure of stress symptoms were high in both groups. These findings are consistent with previously published studies on women with MUI who undergo MUS placement. 5, 19 Thus, it is reasonable to counsel women with preoperative MUI, with or without ISD, that they can expect improvement in their stress-related symptoms.
There are limitations to our study. Our study is primarily limited by the small number of women in the ISD group, and it is possible that we may not have been able to detect differences between groups for life impact, urge incontinence, and other outcomes. In addition, there was a significant difference between groups at baseline in regard to age and detrusor overactivity on preoperative urodynamic testing. We did attempt to control for these confounders in our regression analysis, and the analysis was limited to only these 2 variables because of the small number of women in the ISD group. However, it is certainly possible that these differences could have introduced bias into our results. Also, a fair number of patients were excluded as they did not complete 6-or 12-month validated questionnaires. Potentially, these were women who were more satisfied with the outcome of their surgery and therefore did not present for follow-up. However, there was no difference in the proportion of women lost to follow-up between groups. We believe that this may limit the possible attrition bias. Furthermore, if follow-up had been longer, it is possible that the differences seen between groups may not have persisted. It is also important to note that all women in this study had bothersome stress UI. Whether the majority of women were ''stresspredominant'' or ''urge-predominant'' in our study is less clear. There is no clinically relevant method of defining stress-or urge-predominant MUI that is associated with treatment outcomes. 14 In practice, many women with MUI who first try conservative treatment for OAB become frustrated with results and ultimately choose surgery. Other women with MUI have a difficult time determining which is ''predominant''; they just know they are leaking. Our study would have included all of these women as long as they chose to undergo an MUS placement. However, our study is hypothesis generating and adds to the growing body of literature regarding MUS outcomes in women with MUI.
In conclusion, women with MUI experience improvements in urinary frequency and urge incontinence after MUS. Our
